Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UPDATE: Older Teens Can Get Pfizer-BioNTech Booster Six Months After First Two Doses

-Dow Jones

byBill Haddad

December 9, 2021

1 minute read

-Dow Jones

Avenue Therapeutics Pain Management Treatment Rejected By FDA Again; Shares Drop

By Vandana Singh

Today, 3:39 AM

Avenue Therapeutics Inc (NASDAQ:ATXI) has received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for…

ATXI

Catalyst Pharmaceuticals Announces DyDo Pharma Initiation Of A Phase 3 Study For FIRDAPSE In Japan

By Benzinga Newsdesk

Today, 3:39 AM

Catalyst Pharmaceuticals, Inc. (Catalyst) (NASDAQ:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for

CPRX

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In Q1 2023

By Benzinga Newsdesk

Today, 3:39 AM

In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ:VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major Depressive

CMPS

In Hot, Out Cold: Trump’s 2024 Comeback Looks Bleak If DeSantis Hype Is Real

By AJ Fabino

Today, 3:39 AM

Former President Donald Trump is expected to announce his bid for the 2024 presidential race.

DWAC

UPDATE: Older Teens Can Get Pfizer-BioNTech Booster Six Months After First Two Doses

Related Posts

Avenue Therapeutics Pain Management Treatment Rejected By FDA Again; Shares Drop

Catalyst Pharmaceuticals Announces DyDo Pharma Initiation Of A Phase 3 Study For FIRDAPSE In Japan

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In Q1 2023

In Hot, Out Cold: Trump’s 2024 Comeback Looks Bleak If DeSantis Hype Is Real